Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008.
Nebbioso A, Pereira R, Khanwalkar H, Matarese F, García-Rodríguez J, Miceli M, Logie C, Kedinger V, Ferrara F, Stunnenberg HG, de Lera AR, Gronemeyer H, Altucci L.
Nebbioso A, et al. Among authors: kedinger v.
Mol Cancer Ther. 2011 Dec;10(12):2394-404. doi: 10.1158/1535-7163.MCT-11-0525. Epub 2011 Oct 6.
Mol Cancer Ther. 2011.
PMID: 21980132